OpenEvidence Acquires Google Ventures-Backed AI Startup, Amaro
Amaro was built to help companies analyze and optimize end-to-end advertising deployment using fast, intelligent automation
September 10, 2025
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
Amaro was built to help companies analyze and optimize end-to-end advertising deployment using fast, intelligent automation
The acquisition of the Renew Inserts range will enable Clinisupplies to expand its bowel management offering, while also supporting patients living with chronic bowel issues through its nursing and homecare services.
With this acquisition, Companion Spine continues to expand its mission to safely and effectively treat spine pain through treating lumbar and cervical diseases.
These acquisitions mark a pivotal milestone in Innovia Medical’s continued growth, reinforcing its commitment to building a globally integrated platform of specialty surgical solutions.
The acquisition significantly broadens LICORbio’s electrophoresis offerings, allowing the company to deliver an end-to-end workflow with an expanded suite of products tailored to the evolving needs of proteomics researchers worldwide.
SpringWorks immediately adds revenue and accelerates mid- to long-term growth for Merck KGaA, Darmstadt, Germany’s Healthcare business sector. Acquisition marks the formation of a rare tumor business for Merck KGaA, Darmstadt, Germany including SpringWorks’ portfolio and pimicotinib. SpringWorks’ rare tumor portfolio includes Ogsiveo, a first-in-disease systemic therapy for adults with desmoid tumors and Gomekli a first and only approved therapy for adults and children with NF1-PN.